Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial membrane lipid bilayer is the fundamental structural component forming the boundary of bacterial and other microbial cells. It consists primarily of two layers of amphipathic lipids—mainly phospholipids—with hydrophilic heads facing outward toward aqueous environments and hydrophobic tails oriented inward[3][6]. This arrangement creates a selectively permeable barrier that regulates the passage of ions, nutrients, waste products, and signaling molecules into and out of the cell[1][3][5]. The fluidity and composition can vary depending on species, environmental conditions, and stress responses; for example, bacteria may alter their membrane lipids in response to antibiotic exposure or environmental stressors[2][4][7]. Membrane proteins embedded within this bilayer mediate transport functions as well as signal transduction. The specific composition—including types and ratios of phospholipids such as phosphatidylethanolamine (PE), phosphatidylglycerol (PG), cardiolipin (CL), glycolipids—can differ between Gram-positive and Gram-negative bacteria[7][8]. Some drugs exploit differences in microbial versus mammalian membranes to achieve selective toxicity by disrupting the integrity or function of these membranes. While essential for life—and thus an indirect target for many antimicrobials—the lipid bilayer itself is not considered a classical therapeutic target like an enzyme or receptor. Instead, it serves as a structural feature exploited by certain classes of drugs. Therefore "Microbial membrane lipid bilayer" is not typically classified as a druggable molecular target but rather as a critical cellular structure whose disruption leads to antimicrobial effects. There are no standard biomarkers directly associated with targeting this structure; however, changes in susceptibility to agents that disrupt membranes can serve as functional indicators during drug development. Notably, "The main functions...are to protect the cell, allow selective permeability...and maintain homeostasis"[1]. "Bacteria need to respond quickly...the cell surface [membrane] senses environmental stress..."[2]. "Antibiotics...that perturb synthesis/integrity trigger compensatory stress responses..."[4]. In summary: while vital biologically—and indirectly targeted by some antimicrobials—the microbial membrane lipid bilayer is not itself considered a canonical therapeutic target such as an enzyme or receptor protein.
Disruption of membrane integrity leading to cell lysis or death Alteration of membrane potential or permeability
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial membrane lipid bilayer.